Genomics

Dataset Information

0

Prognostic Liver Signature for NAFLD (PLS-NAFLD) profiles of cell-based PLS system treated with free fatty acids (FFA) and IDO1 inhibitor, epacadostat.


ABSTRACT: Prognostic Liver Signature for NAFLD (PLS-NAFLD) profiles of cell-based PLS system treated with free fatty acids (FFA) and IDO1 inhibitor, epacadostat.

PROVIDER: PRJNA824585 | ENA |

REPOSITORIES: ENA

Similar Datasets

2022-07-01 | GSE200460 | GEO
2019-08-27 | GSE136271 | GEO
2021-12-22 | GSE161841 | GEO
2019-08-27 | GSE136351 | GEO
2021-12-22 | GSE150734 | GEO
2019-08-27 | GSE136278 | GEO
| PRJEB65830 | ENA
2023-12-14 | E-MTAB-13399 | biostudies-arrayexpress
2022-07-01 | GSE192959 | GEO
2022-07-01 | GSE193080 | GEO